CSL Seqirus

News

Falling flu vaccine sales in US stall CSL's Seqirus spinout

CSL says flu vaccination rates in the US are expected to fall 12% to 14% this year, and have scuppered its plan to spin out its vaccines unit Seqirus.

News

CSL will slash headcount and hive off vaccine business

Facing declines in flu vaccination rates in the US, CSL will spin out its vaccine unit as part of a wider restructuring that will claim 3,000 jobs.

News

syringe being filled by hand with vaccine

UK orders 5 million bird flu jabs for pandemic preparedness

The UKHSA has taken steps to prepare for a possible bird flu outbreak by placing an order with Seqirus for millions of H5 vaccine doses.

Falling flu vaccine sales in US stall CSL's Seqirus spinout

CSL will slash headcount and hive off vaccine business

UK orders 5 million bird flu jabs for pandemic preparedness

Servier snaps up cancer biotech Day One in $2.5bn deal

Using AI-driven synthetic personas to take your insights fur...

Editor's Picks